WSJ reports: "Oncology won’t be “a great space for making [AI] products” until there’s better data about patients, spanning genetic, environmental, lifestyle and health information, said Bob Kocher, a medical doctor and partner at venture-capital firm Venrock in Palo Alto, Calif. In the near term, most of the benefits from AI in the health-care field will come in administrative tasks such as billing, he added.
Edited by JPM
Johann Peter Murmann is a professor of strategic management at the University of St. Gallen in Switzerland and editor of economic-evolution.net and has published widely technological and economic evolution. For more information, visit Professor-Murmann.net.